Pharma Partners

Autorizzata da AIFA al confezionamento secondario di farmaci, l'Azienda è anche certificata ISO 13485 per il confezionamento secondario di medical devices e prodotti diagnostici. L'Azienda offre ai propri clienti un servizio con standard elevati di qualità, nel rispetto dei tempi di consegna ed a prezzi competitivi. La definizione delle Responsabilità avviene tramite la stipula di Quality Agreements con i clienti prima dell'inizio di una nuova lavorazione. L'Azienda esegue confezionamenti secondari, riconfezionamenti, sostituzione di componenti, etichettatura, allestimento espositori, allestimento kit diagnostici multicomponente. L'Azienda, pur di recente fondazione, è riuscita a consolidare rapporti stabili con clienti farmaceutici e diagnostici di rilevanza nazionale ed internazionale.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA PARTNERS WITH AFRICAN COUNTRIES ON CHRONIC DISEASES

pharmaphorum.com | February 15, 2017

news image

The Financial Times recently reported that ‘life expectancy in a swath of African countries since 2000 surged by between 20 and 42%’. The average Kenyan could expect to live to be about 52 in 2000 but, by 2014, this had risen to almost 62. As threats from infectious disease and malnutrition reduce, Kenyans can expect to live as long as Americans and Europeans. However, those extra years bring an increased risk of chronic diseases....

Read More

ENABLE INJECTIONS INTRODUCES FIRST MULTI-VIAL/MULTI-SYRINGE BIOLOGICS DELIVERY SYSTEM FOR SEVERAL PHARMA PARTNERS AT BIO 2017

PharmiWeb Solutions | June 19, 2017

news image

Enable Injections, Inc. the developer of advanced large volume wearable injectors (LVWI) for subcutaneous delivery of biologics and high volume drugs, today announced a new single, partial or multi-vial/syringe transfer system for filling its LVWIs. The system provides maximum flexibility by allowing the use of single or multiple vials and single or multiple syringes. It can also be used for variable dosing dependent on a patient's weight....

Read More

UNIVERSAL FLU VACCINE BIOTECH SEEKS BIG PHARMA PARTNERSHIP FOR PHASE 3 TESTING: CEO

fiercepharma | June 19, 2018

news image

Problems with seasonal flu shots have been well documented, and now U.K. biotech Imutex believes it has the next big advance for flu vaccine technology. The company this week reported phase 2b data showing that its universal flu shot, FLU-v, boosted immune responses and lowered infection rates. Imutex is a joint venture between clinical research specialist hVIVO and drug development organization SEEK Group; the team has been working on its universal flu vaccine candidate for 14 years, SEEK CEO G...

Read More

NORTH AMERICA LEADS IN NUMBER OF GLOBAL PHARMA PARTNERSHIPS

European Pharmaceutical Review | October 07, 2019

news image

Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019. According to new research, North America the highest amount of strategic pharma partnerships in the global pharmaceutical industry from 2014 to the first half of 2019. Within this time, over 1,300 separate strategic partnerships and 1,000 licensing agreements were made within pharma worldwide, reveals GlobalData. The industries investigated include gene therapy, immuno-oncology, mi...

Read More
news image

PHARMA PARTNERS WITH AFRICAN COUNTRIES ON CHRONIC DISEASES

pharmaphorum.com | February 15, 2017

The Financial Times recently reported that ‘life expectancy in a swath of African countries since 2000 surged by between 20 and 42%’. The average Kenyan could expect to live to be about 52 in 2000 but, by 2014, this had risen to almost 62. As threats from infectious disease and malnutrition reduce, Kenyans can expect to live as long as Americans and Europeans. However, those extra years bring an increased risk of chronic diseases....

Read More
news image

ENABLE INJECTIONS INTRODUCES FIRST MULTI-VIAL/MULTI-SYRINGE BIOLOGICS DELIVERY SYSTEM FOR SEVERAL PHARMA PARTNERS AT BIO 2017

PharmiWeb Solutions | June 19, 2017

Enable Injections, Inc. the developer of advanced large volume wearable injectors (LVWI) for subcutaneous delivery of biologics and high volume drugs, today announced a new single, partial or multi-vial/syringe transfer system for filling its LVWIs. The system provides maximum flexibility by allowing the use of single or multiple vials and single or multiple syringes. It can also be used for variable dosing dependent on a patient's weight....

Read More
news image

UNIVERSAL FLU VACCINE BIOTECH SEEKS BIG PHARMA PARTNERSHIP FOR PHASE 3 TESTING: CEO

fiercepharma | June 19, 2018

Problems with seasonal flu shots have been well documented, and now U.K. biotech Imutex believes it has the next big advance for flu vaccine technology. The company this week reported phase 2b data showing that its universal flu shot, FLU-v, boosted immune responses and lowered infection rates. Imutex is a joint venture between clinical research specialist hVIVO and drug development organization SEEK Group; the team has been working on its universal flu vaccine candidate for 14 years, SEEK CEO G...

Read More
news image

NORTH AMERICA LEADS IN NUMBER OF GLOBAL PHARMA PARTNERSHIPS

European Pharmaceutical Review | October 07, 2019

Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019. According to new research, North America the highest amount of strategic pharma partnerships in the global pharmaceutical industry from 2014 to the first half of 2019. Within this time, over 1,300 separate strategic partnerships and 1,000 licensing agreements were made within pharma worldwide, reveals GlobalData. The industries investigated include gene therapy, immuno-oncology, mi...

Read More